drugset / Trial / NCT01321931

Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products

NCT01321931

Phase 1 Completed 50 enrolled McNeil AB
RandomizedCrossoverOpen-labelBasic science

Summary

Multiple-dose nicotine pharmacokinetics with three oral nicotine replacement products. A study in healthy smokers.

Timeline

Start
2011-02
Primary completion
2011-05
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicotine Unknown 4 mg Oral
Comparator Nicotine Unknown 6 mg Oral

Indications